Tower Research Capital LLC (Trc) Vyant Bio, Inc. Transaction History

Tower Research Capital LLC (Trc)

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.62 - $1.37 $3,384 - $7,478	-5,459 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$0.99 - $1.61 $1,405 - $2,286	1,420 Added 35.16%	5,459 $8,000
Q4 2021 Feb 14, 2022	BUY	$1.32 - $2.96 $769 - $1,725	583 Added 16.87%	4,039 $5,000
Q3 2021 Nov 15, 2021	SELL	$2.26 - $3.74 $15,684 - $25,955	-6,940 Reduced 66.76%	3,456 $8,000
Q2 2021 Aug 16, 2021	BUY	$2.88 - $4.81 $29,073 - $48,556	10,095 Added 3353.82%	10,396 $39,000
Q1 2021 May 17, 2021	BUY	$2.89 - $8.6 $869 - $2,588	301 New	301 $1,000

213K

Ticker VYNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,343,200
Description
Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule c...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.